- Anaesthesia
- Anatomy
- Biochemistry
- Cardiac Surgery
- Cardiology
- Dentistry
- Dermatology
- Emergency Medicine
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Medicine
- General Surgery
- Genetics
- Geriatrics Medicine
- Health & Nursing
- Hematology
- Histology
- Hospital Administration
- Hospital Management
- Medical Education
- Medicine
- Microbiology
- Nephrology
- Neuro Surgery
- Neurology
- Neuroscience
- Nursing
- Obstetrics & Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Otolaryngology
- Pathology
- Pediatrics
- Pediatrics Surgery
- Pharmacology
- Physiology
- Physiotherapy
- Plastic Surgery
- Preventive And Social Medicine
- Psychiatry
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Transfusion Medicine
- Urology
Pharmacology
THE EU PAEDIATRIC REGULATION PHARMACEUTICALS POLICY AND LAW
ISBN : 9781607500117
Share Link:
Title of the books is THE EU PAEDIATRIC REGULATION PHARMACEUTICALS POLICY AND LAW. Author Name :VALVERDE. Excellent book for the MBBS, 3 Year. Published by IOS PRESS. The EU has been provided with a regulation that promotes and regulates paediatric medicines. The initiation of the preparation of this regulation was made in response to the widespread demand of the scientific community, the health authorities and even of public opinion. The reasons why medicinal products need to be studied in children are clear: more than 50% of the medicines used to treat the children of Europe have not been tested; the paediatric population is a vulnerable group with developmental, physiological and psychological differences from adults; there are differences in pharmacokinetics and dynamics; growth and maturation processes affect them.
Add to Cart
Buy Now
Delivery Charges Applicable
- Satisfaction 100% Guaranteed
- Shipping Charges Applicable
- Latest Editions
Title of the books is THE EU PAEDIATRIC REGULATION PHARMACEUTICALS POLICY AND LAW. Author Name :VALVERDE. Excellent book for the MBBS, 3 Year. Published by IOS PRESS. The EU has been provided with a regulation that promotes and regulates paediatric medicines. The initiation of the preparation of this regulation was made in response to the widespread demand of the scientific community, the health authorities and even of public opinion. The reasons why medicinal products need to be studied in children are clear: more than 50% of the medicines used to treat the children of Europe have not been tested; the paediatric population is a vulnerable group with developmental, physiological and psychological differences from adults; there are differences in pharmacokinetics and dynamics; growth and maturation processes affect them.
Specifications
| Author | VALVERDE |
| Edition | CURRENT EDITION |
| Year | 2009 |
| Publisher | IOS PRESS |
| Binding | HARDCOVER |
Product Reviews
There are no reviews yet.
Write Review